"Investigation of the relationship between the recurrence of non-muscle invasive bladder cancer (NMIBC) and intake of the therapeutic agent for dysuria."
Not Applicable
- Conditions
- The non-muscle invasive bladder cancer (NMIBC)
- Registration Number
- JPRN-UMIN000036097
- Lead Sponsor
- Iwate Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria were the case have past history of primary upper urinary cancer or were the cases with a follow-up period of less than 6 months.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EORTC recurrence score and CUETO recurrence score are calculated of each patient, 2nd TUR-BT and BCG therapy, kinds of current or past of medication history of therapeutic agent for dysuria and recurrence status are recorded.
- Secondary Outcome Measures
Name Time Method